Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma
Clinical trial NCT05021770 · UNKNOWN
Trial details
- NCT number
- NCT05021770
- Sponsor
- Huiqiang Huang
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-12-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.